• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 p

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Oct 15.
doi: 10.1002/jmv.26601. Online ahead of print.
Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients


Yazdan Yazdanpanah[SUP] 1 2 [/SUP], French COVID cohort study group



Affiliations

Abstract

Objectives: We conducted a multicentric prospective cohort of COVID-19 hospitalized patients to describe clinical, biological and virological characteristics at hospital admission and over time according to mortality up to Day 60 after admission.
Methods: For the analysis of risk factors of survival, analyses assessing associations between mortality and demographic characteristics or comorbidities were performed using a Cox regression model.
Results: Between January 24[SUP]th[/SUP] and March 15[SUP]th[/SUP] 2020, 246 patients with RT-PCR virologically-confirmed COVID-19 were enrolled. In multivariate analysis, mortality at Day 60 (n=42 patients, 17.1% [95%CI: 12.6 to 22.4]) was associated with older age (aHR for age ≥65 years: 5.22 [2.56 to 10.63, P<.001]), gender (aHR for male: 2.97 [1.47 to 5.99, P=.002]), chronic pulmonary disease (aHR: 4.84 [2.32 to 10.07, P<.001]), obesity (aHR: 3.32 [1.70 to 6.52, P<.001]) and diabetes (aHR: 1.98 [1.01 to 3.89, P=.048]).The median nasopharyngeal viral load at admission was 6.4 log[SUB]10[/SUB] copies/mL and was associated with mortality regardless of clinical risk factors. Viral load decreased with time elapsed since symptoms onset.
Conclusions: Mortality was associated with clinical characteristics at admission. The viral load at admission was significantly lower in patients admitted late after onset of symptoms in both dead and alive patients. This article is protected by copyright. All rights reserved.
 
Back
Top Bottom